Piramal Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹2,751.77 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.60 per cent from ₹2,139.87 crore. This corresponds to a year-on-year *(YoY) decline of 0.08 per cent.
Operating Profit
Operating Profit stands at ₹284.74 crore, reflecting a quarter-on-quarter *(QoQ) increase of 84.15 per cent from ₹154.62 crore. This corresponds to a year-on-year *(YoY) decline of 49.24 per cent.
PBDT
PBDT stands at ₹261.38 crore, reflecting a quarter-on-quarter *(QoQ) increase of 119.87 per cent from ₹118.88 crore. This corresponds to a year-on-year *(YoY) decline of 49.30 per cent.
Profit Before Tax
Profit Before Tax stands at ₹43.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 145.81 per cent from ₹-93.86 crore. This corresponds to a year-on-year *(YoY) decline of 84.24 per cent.
Net Profit
Net Profit stands at ₹-8.83 crore, reflecting a quarter-on-quarter *(QoQ) increase of 93.52 per cent from ₹-136.19 crore. This represents a 105.75 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Piramal Pharma Ltd News
Piramal Pharma Ltd Earnings
- YOY
- QOQ
Piramal Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Piramal Pharma Ltd Research Reports
Piramal Pharma Ltd Financial Reports
Piramal Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Piramal Pharma | -0.66% | 3.42% | 3.02% | 21.73% | 3.17% | -13.72% |
| Acutaas Chemical | 2.11% | -5.75% | 8.73% | 49.85% | 106.04% | 208.89% |
| Sai Life | 0.44% | -1.41% | -0.71% | 24.66% | 32.06% | 56.71% |
| Neuland Labs. | 0.92% | 0.62% | 11.21% | 29.64% | 29.26% | 59.55% |
| Rubicon Research | -1.34% | -0.63% | 16.78% | 59.52% | 110.29% | 117.70% |
| Granules India | -0.16% | 4.00% | 12.37% | 35.32% | 42.72% | 79.29% |
| Pfizer | 0.57% | 3.22% | -0.12% | -3.53% | -5.97% | -19.18% |
Company Info
Company Information
Chairperson & Whole Time Director : Nandini Piramal
WTD & Executive Director : PETER D DEYOUNG
Executive Director & CFO : Vivek Valsaraj
Non-Exec & Non-Independent Dir : Amit Jain
Independent Non Exe. Director : S Rama Dorai
Independent Non Exe. Director : Jairaj Manohar Purandare
Independent Non Exe. Director : Sridhar Gorthi
Independent Non Exe. Director : Peter Stevenson
Non-Exec & Non-Independent Dir : Nathalie Leitch
Independent Non Exe. Director : Vibha Paul Rishi
Company Sec. & Compli. Officer : Maneesh Sharma